B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastoma.
about
CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant GliomasPositive and negative functions of B lymphocytes in tumorsImmune Evasion Strategies of GlioblastomaOverview of current immunotherapeutic strategies for gliomaImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesGene therapy for brain tumors: basic developments and clinical implementationMarmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors.Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.Therapeutic antitumor efficacy of B cells loaded with tumor-derived autophagasomes vaccine (DRibbles)Alocasia cucullata exhibits strong antitumor effect in vivo by activating antitumor immunityThe interconnectedness of cancer cell signaling.A new paradigm for an old story: the role of regulatory B cells in cancerPlasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms.Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaPreclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma ModelRecent advances and future of immunotherapy for glioblastoma.Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity.Cancer subclonal genetic architecture as a key to personalized medicine.Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models.Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCsOvercoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationB lymphocytes and cancer: a love-hate relationship.Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.Therapeutic blockade of Foxp3 in experimental breast cancer models.Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide.Current state and future prospects of immunotherapy for glioma.Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.
P2860
Q26740520-70D9EE5A-ABBD-4DFC-83DA-5D049A1B9B58Q26743398-57604AA8-1CA6-42AB-AB15-EE6B692C295CQ26765855-1FA4E46E-65A2-41AE-A60F-5BC1D2F20806Q26776345-032609AD-FCB7-465B-936B-C3A44A614340Q26798402-8B162162-951E-4F29-BF95-C0A8EEE6D2AFQ26829086-EAE05F00-B1A0-41BF-9EA3-D106A712D6A1Q33950709-28DFB4A2-0FAA-46A6-936A-2F5CB65808F4Q34103969-76291CE8-0D06-4E0F-8065-7247999454ECQ34196895-A7159D72-6BB9-4E5D-A274-584BB7A0B991Q35005565-3D6E0251-B244-4981-A537-F791F3C9F547Q35669733-96870722-6191-4AF1-A28D-459140E0D142Q36107944-08DD8F19-1EF8-49C2-B479-0AE835CF2105Q36200438-FFA75225-0604-4277-9BA6-1A643976EFB3Q36367568-39015488-64DA-4FDA-BA5D-5060627AA6B5Q36745357-DB92B74C-4198-4E50-803F-6951B62AB5DBQ36811505-0D021170-991D-4F7A-B644-CA2E19CC76E7Q37050094-B38E73F2-0FA6-44E1-93A8-5059D11CE958Q37239071-CA4AF317-11D4-43F2-AB49-D71D98618F0AQ37327460-6F650775-F9B6-4A43-909F-B491F5B4B3F8Q37448116-A70C1F9E-75CC-4CB5-B6C1-BB7985FC942AQ37647868-2BDE1695-A276-419B-A2E9-53F806099748Q37687506-DB1091D1-056E-4A3C-9DAE-796DB40F0AF4Q38843707-3A02DF45-06D4-4894-ACC4-945AA5AC8F2EQ41140076-E6B41129-0775-48FF-A156-3FEB2AA47A01Q41879186-7BFC1A6D-191D-4236-BC5A-762B136B8B69Q44779139-71F2E3DC-AEB9-483D-BF9C-AE56AA64FF76Q45864012-0AA97618-984B-464A-9E95-8555B714552FQ48325267-CACDE62E-425A-4FD6-AB34-172E96D9E7CCQ48379910-5471D5AA-F25F-4190-A4DB-CED74F166AA3Q50109459-B4364B30-D96C-45D7-9F1A-787C56CAAF18Q52757687-48AEEF24-4D21-43FB-9D80-D12559D5FEEC
P2860
B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
B cells are critical to T-cell ...... oxic therapy for glioblastoma.
@ast
B cells are critical to T-cell ...... oxic therapy for glioblastoma.
@en
type
label
B cells are critical to T-cell ...... oxic therapy for glioblastoma.
@ast
B cells are critical to T-cell ...... oxic therapy for glioblastoma.
@en
prefLabel
B cells are critical to T-cell ...... oxic therapy for glioblastoma.
@ast
B cells are critical to T-cell ...... oxic therapy for glioblastoma.
@en
P2093
P2860
P356
P1433
P1476
B cells are critical to T-cell ...... toxic therapy for glioblastoma
@en
P2093
A K M G Muhammad
Chunyan Liu
David Foulad
Gabrielle E Alzadeh
Gislaine Martins
Hikmat Assi
Kader Yagiz
Kurt M Kroeger
Mariana Puntel
Marianela Candolfi
P2860
P304
P356
10.1593/NEO.11024
P577
2011-10-01T00:00:00Z